P3 Health Partners
PIII
62 hedge funds and large institutions have $83.7M invested in P3 Health Partners in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 1 closing their positions.
1,600% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 1
314% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 7
248% more capital invested
Capital invested by funds: $24M → $83.7M (+$59.6M)
35% more funds holding
Funds holding: 46 → 62 (+16)
0.6% less ownership
Funds ownership: 1.09% → 0.49% (-0.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.1M |
| 2 |
BlackRock
New York
|
+$2.2M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$860K |
| 4 |
EL
EMFO LLC
Weston,
Florida
|
+$756K |
| 5 |
State Street
Boston,
Massachusetts
|
+$678K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$1.93M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.49M |
| 3 |
Millennium Management
New York
|
-$159K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$49.5K |
| 5 |
HF
HRT Financial
New York
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ISL
51
Ingalls & Snyder LLC
New York
| $30K | – | – | – |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $27.4K | -$5.53K | -40 | -18% |
|
|
AB
53
Amalgamated Bank
New York
| $16K | +$3.04K | +22 | +26% |
|
54
Allspring Global Investments
Charlotte,
North Carolina
| $14.8K | +$13.7K | +99 | New |
|
55
Legal & General Group
London,
United Kingdom
| $14.5K | +$6.5K | +47 | +94% |
|
|
56
Bank of America
Charlotte,
North Carolina
| $13.9K | -$49.5K | -358 | -79% |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| $9K | +$1.52K | +11 | +21% |
|
|
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
| $6.96K | +$6.5K | +47 | New |
|
|
AIP
59
Ameritas Investment Partners
Lincoln,
Nebraska
| $5.71K | – | – | – |
|
|
WAM
60
Wolverine Asset Management
Chicago,
Illinois
| $3.92K | +$3.59K | +26 | New |
|
|
TCM
61
Tuttle Capital Management
Riverside,
Connecticut
| $2.85K | – | – | – |
|
|
CFGS
62
Concourse Financial Group Securities
Birmingham,
Alabama
| $598 | – | – | – |
|
63
Nisa Investment Advisors
St. Louis,
Missouri
| $63 | – | – | – |
|
|
HF
64
HRT Financial
New York
| – | -$46K | -878 | Closed |
|
PIII Hedge Fund Activity: Q2 2023 in Review
62 of the 6,372 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2023, worth a combined $83.7M — up 248% from $24M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PIII positions and 1 closed out — a net gain of 16 holders — while 29 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $10.1M. The largest seller was Janus Henderson Group, cutting an estimated $1.93M.
- 62 institutional investors held P3 Health Partners (PIII) as of Q2 2023, up from 46 in Q1 2023.
- Funds reported $83.7M of P3 Health Partners stock for Q2 2023, up 248% quarter-over-quarter.
- 17 funds opened new P3 Health Partners positions in Q2 2023 and 1 closed out, a net change of +16 holders.
- The largest P3 Health Partners buyer in Q2 2023 was Vanguard Group, an estimated $10.1M added.
- The largest P3 Health Partners seller in Q2 2023 was Janus Henderson Group, an estimated $1.93M sold.
Based on aggregated 13F filings for Q2 2023.